Metronomic Celecoxib Therapy in Clinically Available Dosage Ablates Hepatocellular Carcinoma via Suppressing Cell Invasion, Growth, and Stemness in Pre-Clinical Models.

Published in:

Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.572861

By:

• Yeh, Chun-Chieh;
• Liao, Pei-Ying;
• Pandey, Sudhir;
• Yung, Su-Yung;
• Lai, Hsueh-Chou;
• Jeng, Long-Bin;
• Chang, Wei-Chun;
• Ma, Wen-Lung

Publication type:

Article